Intratumoral heterogeneity of genomic imbalance in a case of epithelioid glioblastoma with BRAF V600E mutation

Brain Pathology

Volumn 24, Issue 3, 2014, Pages 239-246

  Nobusawa, Sumihito ^a   Hirato, Junko ^b   Kurihara, Hideyuki ^c   Ogawa, Akira ^c   Okura, Naoki ^d   Nagaishi, Masaya ^a,e   Ikota, Hayato ^a   Yokoo, Hideaki ^a   Nakazato, Yoichi ^a,f  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b GUNMA UNIVERSITY HOSPITAL   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION TAKASAKI GENERAL MEDICAL CENTER   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e DOKKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f Hidaka Hospital   (Japan)

Author keywords

array CGH; BRAF; epithelioid glioblastoma; LSAMP

Indexed keywords

BETA INTERFERON; GADOLINIUM; TEMOZOLOMIDE; B RAF KINASE; BRAF PROTEIN, HUMAN; GLUTAMIC ACID; IDH1 PROTEIN, HUMAN; ISOCITRATE DEHYDROGENASE; VALINE;

ADULT; ARTICLE; BRAF GENE; BRAIN HEMORRHAGE; BRAIN TUMOR; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CASE REPORT; CHROMOSOME ANALYSIS; COMPARATIVE GENOMIC HYBRIDIZATION; CONSERVATIVE TREATMENT; CONTRAST ENHANCEMENT; DNA SEQUENCE; EPITHELIOID GLIOBLASTOMA; FEMALE; GENE; GENE DELETION; GENE MUTATION; GENETIC ASSOCIATION; GLIOBLASTOMA; HEADACHE; HEMATOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IDH1 GENE; IDH2 GENE; IMMUNOHISTOCHEMISTRY; LSAMP GENE; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL LOBE; TUMOR RECURRENCE; TUMOR SUPPRESSOR GENE; YOUNG ADULT; GENETICS; MALE; NUCLEOTIDE SEQUENCE; PATHOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM;

BRAIN NEOPLASMS; DNA MUTATIONAL ANALYSIS; GLIOBLASTOMA; GLUTAMIC ACID; HUMANS; ISOCITRATE DEHYDROGENASE; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTO-ONCOGENE PROTEINS B-RAF; VALINE; YOUNG ADULT;

EID: 84898545824     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/bpa.12114     Document Type: Article

References (37)

1. Arai M, Nobusawa S, Ikota H, Takemura S, Nakazato Y, (2012) Frequent IDH1/2 mutations in intracranial chondrosarcoma: a possible diagnostic clue for its differentiation from chordoma. Brain Tumor Pathol 29: 201-206.
2. Babu R, Hatef J, McLendon RE, Cummings TJ, Sampson JH, Friedman AH, Adamson C, (2013) Clinicopathological characteristics and treatment of rhabdoid glioblastoma. J Neurosurg 119: 412-419.
3. Brennan CW, Verhaak RG, McKenna A, Campos B, Noushmehr H, Salama SR, et al (2013) The somatic genomic landscape of glioblastoma. Cell 155: 462-477.
4. Broniscer A, Tatevossian RG, Sabin ND, Klimo P Jr, Dalton J, Lee R, et al (2013) Clinical, radiological, histological, and molecular characteristics of paediatric epithelioid. Neuropathol Appl Neurobiol doi: 10.1111/nan.12093.
5. Chen J, Lui WO, Vos MD, Clark GJ, Takahashi M, Schoumans J, et al (2003) The t(1;3) breakpoint-spanning genes LSAMP and NORE1 are involved in clear cell renal cell carcinoma. Cancer Cell 4: 405-413.
6. Dias-Santagata D, Lam Q, Vernovsky K, Vena N, Lennerz JK, Borger DR, et al (2011) BRAF V600E mutations are common in pleomorphic xanthoastrocytoma: diagnostic and therapeutic. PLoS ONE 6: e17948.
7. Ding L, Getz G, Wheeler DA, Mardis ER, McLellan MD, Cibulskis K, et al (2008) Somatic mutations affect key pathways in lung adenocarcinoma. Nature 455: 1069-1075.
8. Dougherty MJ, Santi M, Brose MS, Ma C, Resnick AC, Sievert AJ, et al (2010) Activating mutations in BRAF characterize a spectrum of pediatric low-grade gliomas. Neuro-Oncol 12: 621-630.
9. Forshew T, Tatevossian RG, Lawson AR, Ma J, Neale G, Ogunkolade BW, et al (2009) Activation of the ERK/MAPK pathway: a signature genetic defect in posterior fossa pilocytic astrocytomas. J Pathol 218: 172-181.
10. He MX, Wang JJ, (2011) Rhabdoid glioblastoma: case report and literature review. Neuropathology 31: 421-426.
11. Huang H, Colella S, Kurrer M, Yonekawa Y, Kleihues P, Ohgaki H, (2000) Gene expression profiling of low-grade diffuse astrocytomas by cDNA arrays. Cancer Res 60: 6868-6874.
12. Kim YH, Lachuer J, Mittelbronn M, Paulus W, Brokinkel B, Keyvani K, et al (2011) Alterations in the RB1 pathway in low-grade diffuse gliomas lacking common genetic alterations. Brain Pathol 21: 645-651.
13. Kleihues P, Burger PC, Aldape KD, Brat DJ, Biernat W, Bigner DD, (2007) Glioblastoma. Chapter 1. In: WHO Classification of Tumours of the Central Nervous System., DN Louis, H Ohgaki, OD Wiestler, WK Cavenee, (eds), pp. 33-59. IARC Press: Lyon.
14. Kleinschmidt-DeMasters BK, Aisner DL, Birks DK, Foreman NK, (2013) Epithelioid GBMs show a high percentage of BRAF V600E mutation. Am J Surg Pathol 37: 685-698.
15. Kleinschmidt-DeMasters BK, Alassiri AH, Birks DK, Newell KL, Moore W, Lillehei KO, (2010) Epithelioid versus rhabdoid glioblastomas are distinguished by monosomy 22 and immunohistochemical expression of INI-1 but not claudin 6. Am J Surg Pathol 34: 341-354.
16. Koelsche C, Wöhrer A, Jeibmann A, Schittenhelm J, Schindler G, Preusser M, et al (2013) Mutant BRAF V600E protein in ganglioglioma is predominantly expressed by neuronal tumor cells. Acta Neuropathol 125: 891-900.
17. Kresse SH, Ohnstad HO, Paulsen EB, Bjerkehagen B, Szuhai K, Serra M, et al (2009) LSAMP, a novel candidate tumor suppressor gene in human osteosarcomas, identified by array comparative genomic hybridization. Genes Chromosomes Cancer 48: 679-693.
18. Lath R, Unosson D, Blumbergs P, Stahl J, Brophy BP, (2003) Rhabdoid glioblastoma: a case report. J Clin Neurosci 10: 325-328.
19. Letouzé E, Rosati R, Komechen H, Doghman M, Marisa L, Flück C, et al (2012) SNP array profiling of childhood adrenocortical tumors reveals distinct pathways of tumorigenesis and highlights candidate driver genes. J Clin Endocrinol Metab 97: E1284-E1293.
20. Lv SQ, Kim YH, Giulio F, Shalaby T, Nobusawa S, Yang H, et al (2012) Genetic alterations in microRNAs in medulloblastomas. Brain Pathol 22: 230-239.
21. Momota H, Iwami K, Fujii M, Motomura K, Natsume A, Ogino J, et al (2011) Rhabdoid glioblastoma in a child: case report and literature review. Brain Tumor Pathol 28: 65-70.
22. Nagayama K, Kohno T, Sato M, Arai Y, Minna JD, Yokota J, (2007) Homozygous deletion scanning of the lung cancer genome at a 100-kb resolution. Genes Chromosomes Cancer 46: 1000-1010.
23. Nakamura M, Watanabe T, Klangby U, Asker C, Wiman K, Yonekawa Y, et al (2001) P14Arf deletion and methylation in genetic pathways to glioblastomas. Brain Pathol 11: 159-168.
24. Nakazato Y, Ishizeki J, Takahashi K, Yamaguchi H, Kamei T, Mori T, (1982) Localization of S-100 protein and glial fibrillary acidic protein-related antigen in pleomorphic adenoma of the salivary glands. Lab Invest 46: 621-626.
25. Nikolaev SI, Rimoldi D, Iseli C, Valsesia A, Robyr D, Gehrig C, et al (2011) Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma. Nat Genet 44: 133-139.
26. Nobusawa S, Lachuer J, Wierinckx A, Kim YH, Huang J, Legras C, et al (2010) Intratumoral patterns of genomic imbalance in glioblastomas. Brain Pathol 20: 936-944.
27. Pasic I, Shlien A, Durbin AD, Stavropoulos DJ, Baskin B, Ray PN, et al (2010) Recurrent focal copy-number changes and loss of heterozygosity implicate two noncoding RNAs and one tumor suppressor gene at chromosome 3q13.31 in osteosarcoma. Cancer Res 70: 160-171.
28. Pimentel J, Silva R, Pimentel T, (2003) Primary malignant rhabdoid tumors of the central nervous system: considerations about two cases of adulthood presentation. J Neurooncol 61: 121-126.
29. Rollbrocker B, Waha A, Louis DN, Wiestler OD, von Deimling A, (1996) Amplification of the cyclin-dependent kinase 4 (CDK4) gene is associated with high cdk4 protein levels in glioblastoma multiforme. Acta Neuropathol 92: 70-74.
30. Schiffman JD, Hodgson JG, VandenBerg SR, Flaherty P, Polley MY, Yu M, et al (2010) Oncogenic BRAF mutation with CDKN2A inactivation is characteristic of a subset of pediatric astrocytomas. Cancer Res 70: 512-519.
31. Schindler G, Capper D, Meyer J, Janzarik W, Omran H, Herold-Mende C, et al (2011) Analysis of BRAF V600E mutation in 1320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma. Acta Neuropathol 121: 397-405.
32. Tagawa H, Karnan S, Suzuki R, Matsuo K, Zhang X, Ota A, et al (2005) Genome-wide array-based CGH for mantle cell lymphoma: identification of homozygous deletions of the proapoptotic gene BIM. Oncogene 24: 1348-1358.
33. Tohma Y, Gratas C, Biernat W, Peraud A, Fukuda M, Yonekawa Y, et al (1998) PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas. J Neuropathol Exp Neurol 57: 684-689.
34. Watanabe T, Nobusawa S, Kleihues P, Ohgaki H, (2009) IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas. Am J Pathol 174: 1149-1153.
35. Yen CC, Chen WM, Chen TH, Chen WY, Chen PC, Chiou HJ, et al (2009) Identification of chromosomal aberrations associated with disease progression and a novel 3q13.31 deletion involving LSAMP gene in osteosarcoma. Int J Oncol 35: 775-788.
36. Yokoo H, Kinjo S, Hirato J, Nakazato Y, (2006) Fluorescence in situ hybridization targeted for chromosome 1p of oligodendrogliomas (in Japanese). Rinsho Kensa 50: 761-766.
37. Yokoo H, Nobusawa S, Takebayashi H, Ikenaka K, Isoda K, Kamiya M, et al (2004) Anti-human Olig2 antibody as a useful immunohistochemical marker of normal oligodendrocytes and gliomas. Am J Pathol 164: 1717-1725.